Highlights China NT Pharma Group Company Limited

Equities

1011

KYG2114L1059

Delayed Hong Kong S.E. Other stock markets 07:12:12 26/06/2024 am IST			5-day change	1st Jan Change
0.033 ^HKD	+3.12%		+23.08%	-41.82%

07/06	China NT Pharma Shareholders to Vote June 28 on Proposed Share Consolidation	MT
29/05	China NT Pharma Group Company Limited Announces Change of Address of the Principal Place of Business and Headquarters	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

China NT Pharma Shareholders to Vote June 28 on Proposed Share Consolidation	07/06	MT
China NT Pharma Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	28/03	CI
China NT Pharma Group Company Limited Announces Change of Company Secretary, Effective 31 December 2023	29/12	CI
China NT Pharma Group, Private Equity Fund Sign Cooperation Agreement; Shares Rise 4%	10/23/10	MT
China NT Pharma Group Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023	31/23/31	CI
China NT Pharma Lays Out Restructuring Plan for Embattled Unit Suzhou First Pharma	27/23/27	MT
China NT Pharma Unit Faces Lawsuits for Alleged Loan Default	02/23/02	MT
China NT Pharma Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022	31/23/31	CI
Konruns Pharma Cancels Osteoporosis Drug Agreement With NT Pharma, US-based Pfenex	20/22/20	MT
China NT Pharma Group Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022	31/22/31	CI
China NT Pharma Group Company Limited Intends to Set Up A Joint Venture Company	17/22/17	CI
China NT Pharma Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021	31/22/31	CI
China NT Pharma : Narrows H1 Loss on Increased Antipsychotic Drug Sales	01/21/01	MT
China NT Pharma Group Company Limited Reports Earnings Results for the Half Year Ended June 30, 2021	31/21/31	CI
China NT Pharma Group Company Limited Provides Group Earnings Guidance for the Six Months Ended 30 June 2021	27/21/27	CI
Fortune Blaze Investments Limited completed the acquisition of The Mountains Limited from China NT Pharma Group Company Limited.	02/21/02	CI
China NT Pharma : Logs Lower Loss in 2020 as Revenue Soars 44%	06/21/06	MT
China NT Pharma Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2020	31/21/31	CI
China NT Pharma : Board Urges Shareholders to Approve $10 Million Sale of Industrial Land	13/21/13	MT
Fortune Blaze Investments Limited entered into an agreement to acquire The Mountains Limited from China NT Pharma Group Company Limited for approximately CNY 130 million.	13/21/13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights China NT Pharma Group Company Limited

Equities

1011

KYG2114L1059

Highlights

Filters